Holen Sie sich die Stockscreener-App
4.76
3.94%
-0.195
Handel nachbörslich:
4.76
Abeona Therapeutics Inc Aktie (ABEO) Neueste Nachrichten
Abeona Therapeutics Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
Abeona reports progress in ZEVASKYN gene therapy launch - Investing.com Nigeria
Q4 EPS Forecast for Abeona Therapeutics Increased by Analyst - MarketBeat
HC Wainwright Has Bullish Outlook for ABEO FY2025 Earnings - MarketBeat
Abeona Therapeutics Says ZEVASKYN Launch Is Back on Track, Eyes Profitability in 2026 - MarketBeat
Abeona Therapeutics at Leerink Global Healthcare Conference: Strategic Launch Insights - Investing.com Canada
HC Wainwright Reaffirms "Buy" Rating for Abeona Therapeutics (NASDAQ:ABEO) - MarketBeat
Abeona Therapeutics (ABEO) Receives Consistent Analyst Rating of "Buy" | ABEO Stock News - GuruFocus
Oppenheimer Maintains Outperform on Abeona Therapeutics (ABEO) PT $22 March 2026 - Meyka
Oppenheimer raises Abeona Therapeutics price target on launch progress - Investing.com
Abeona Therapeutics Announces Momentum in ZEVASKYN® Gene Therapy Launch for Recessive Dystrophic Epidermolysis Bullosa (RDEB) - Minichart
Abeona Therapeutics (ABEO) Progress with Zevaskyn Launch - GuruFocus
Abeona Accelerates ZEVASKYN Commercial Momentum and Market Access - TipRanks
Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch - The Manila Times
Abeona Therapeutics reports early commercial momentum and payer coverage for ZEVASKYN launch - TradingView
Gene therapy ZEVASKYN gains broad insurance coverage for RDEB patients - Stock Titan
Abeona Therapeutics Announces Date of Fourth Quarter, Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference - marketscreener.com
Abeona Therapeutics Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference - 富途牛牛
Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference - marketscreener.com
Avoiding Lag: Real-Time Signals in (ABEO) Movement - Stock Traders Daily
Abeona Therapeutics Inc. $ABEO Shares Sold by Western Standard LLC - MarketBeat
Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a Potential 289% Upside in Gene Therapy Innovations - DirectorsTalk Interviews
Abeona Therapeutics (NASDAQ:ABEO) Stock Passes Above 50-Day Moving AverageHere's What Happened - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Vanda (VNDA), Abeona Therapeutics (ABEO) - The Globe and Mail
Is Abeona Therapeutics Inc. a strong growth stockInflation Watch & Safe Entry Momentum Tips - mfd.ru
Big Picture: Does Abeona Therapeutics Inc have strong EBITDA marginsJuly 2025 EndofMonth & Safe Entry Zone Tips - baoquankhu1.vn
Discipline and Rules-Based Execution in ABEO Response - Stock Traders Daily
Abeona Therapeutics Inc. (NASDAQ:ABEO) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Epidermolysis Bullosa Clinical Trial Pipeline Robust as 20+ - openPR.com
Is Abeona Therapeutics Inc. (PCJ) stock undervalued by metricsJuly 2025 Price Swings & Low Drawdown Trading Strategies - mfd.ru
Published on: 2026-02-14 07:33:27 - mfd.ru
ABEO SEC FilingsAbeona Therapeut 10-K, 10-Q, 8-K Forms - Stock Titan
Is Abeona Therapeutics Inc. stock overvalued or fairly priced2025 Buyback Activity & Fast Moving Stock Watchlists - mfd.ru
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Seven new Abeona hires get 3-year stock grants as inducement - Stock Titan
Behavioral Patterns of ABEO and Institutional Flows - Stock Traders Daily
Abeona Therapeutics Inc. (ABEO) Investor Outlook: Unpacking A 306% Potential Upside - DirectorsTalk Interviews
Abeona Therapeutics (NASDAQ:ABEO) Director Sells 20,070 Shares - MarketBeat
Abeona sells Rare Pediatric Disease PRV for $155M - MSN
Abeona Therapeutics director sells $75k in stock - Investing.com India
Abeona Therapeutics director sells $75k in stock By Investing.com - Investing.com South Africa
Crombez Eric sells Abeona Therapeutics (ABEO) shares for $82895 By Investing.com - Investing.com Nigeria
Crombez Eric sells Abeona Therapeutics (ABEO) shares for $82895 - Investing.com
Abeona Therapeutics (NASDAQ:ABEO) Director Eric Crombez Sells 16,284 Shares - MarketBeat
Abeona Therapeutics (NASDAQ:ABEO) Director Mark Alvino Sells 2,000 Shares - MarketBeat
Leila Alland Sells 18,065 Shares of Abeona Therapeutics (NASDAQ:ABEO) Stock - MarketBeat
Insider-Favored Growth Companies To Watch February 2026 - simplywall.st
Merger Talk: Is Abeona Therapeutics Inc in a bullish channelSwing Trade & Stock Timing and Entry Methods - baoquankhu1.vn
Sentiment Watch: How does FVNNU score in quality rankingsBond Market & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Dividend Watch: How does CBTJ correlate with NasdaqWeekly Gains Summary & Accurate Buy Signal Notifications - baoquankhu1.vn
Is Abeona Therapeutics Inc. stock forming a cup and handleJuly 2025 Highlights & Reliable Volume Spike Alerts - mfd.ru
Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a 327% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):